Canlyniadau Chwilio - Erin D. Michos

Mireinio'r Canlyniadau
  1. 1
    Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.

    Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S. gan Erin D. Michos, Roger S. Blumenthal

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies

    Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies gan Pamela L. Lutsey, Erin D. Michos

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey

    The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey gan Mohsen Mazidi, Erin D. Michos, Maciej Banach

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention

    Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention gan Olatokunbo Osibogun, Oluseye Ogunmoroti, Erin D. Michos

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic

    Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic gan Eamon Duffy, Miguel Cainzos‐Achirica, Erin D. Michos

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis

    Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis gan Yash Maniar, Ahmad Al‐Abdouh, Erin D. Michos

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity

    Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity gan Erin D. Michos, Francisco López-Jiménez, Martha Gulati

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Hormone Replacement Therapy and the Cardiovascular System

    Hormone Replacement Therapy and the Cardiovascular System gan Pamela Ouyang, Erin D. Michos, Richard H. Karas

    Cyhoeddwyd 2006
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention

    Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention gan Petal Elder, Garima Sharma, Martha Gulati, Erin D. Michos

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    COVID and Cardiovascular Disease: What We Know in 2021

    COVID and Cardiovascular Disease: What We Know in 2021 gan Michael Chilazi, Eamon Duffy, Aarti Thakkar, Erin D. Michos

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum

    Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum gan Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?

    A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? gan Alaa Diab, Lily Nedda Dastmalchi, Martha Gulati, Erin D. Michos

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population

    25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population gan Michal L. Melamed, Erin D. Michos, Wendy S. Post, Brad C. Astor

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease

    Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease gan Jared P. Reis, Erin D. Michos, Denise von Mühlen, Edgar R. Miller

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Aspirin and Clopidogrel Resistance

    Aspirin and Clopidogrel Resistance gan Erin D. Michos, Reza Ardehali, Roger S. Blumenthal, Richard A. Lange, Hossein Ardehali

    Cyhoeddwyd 2006
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events

    Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events gan Erin D. Michos, Christopher T. Sibley, Jefferson Baer, Michael J. Blaha, Roger S. Blumenthal

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Adverse pregnancy outcomes and future maternal cardiovascular disease

    Adverse pregnancy outcomes and future maternal cardiovascular disease gan Alisse Hauspurg, Wendy Ying, Carl A. Hubel, Erin D. Michos, Pamela Ouyang

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk

    The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk gan Anandita Agarwala, Erin D. Michos, Zainab Samad, Christie M. Ballantyne, Salim S. Virani

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection

    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection gan Erin D. Michos, George L. Bakris, Helena W. Rodbard, Katherine R. Tuttle

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    High lipoprotein(a): Actionable strategies for risk assessment and mitigation

    High lipoprotein(a): Actionable strategies for risk assessment and mitigation gan Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, Wess Boatwright, Christie M. Ballantyne

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: